LUNAR: a randomized Phase 2 study of 177Lutetium-PSMA Neoadjuvant to Ablative Radiotherapy for Oligorecurrent Prostate Cancer (clinical trial protocol) The aim of this study is to assess the efficacy of 177Lu-PNT2002, a novel radiolabelled small molecule that binds with high affinity to prostate-specific membrane antigen, in combination with stereotactic body radiotherapy (SBRT) to all sites of metastasis, […]
[#feed_custom_content:encoded]
[#feed_custom_content:encoded]
Is low-dose tadalafil better than tamsulosin? A randomized controlled trial in shockwave lithotripsy for solitary upper tract calculi The aim of this work is to ascertain whether low-dose tadalafil (5 mg) is more efficient than tamsulosin (0.4 mg) in facilitating calculus expulsion in those receiving extracorporeal shockwave lithotripsy for solitary upper urinary tract calculi. Madhuri Evangeline Sadanala, […]
[#feed_custom_content:encoded]
[#feed_custom_content:encoded]
[#feed_custom_content:encoded]
[#feed_custom_content:encoded]
Part of the BJUI/BURST podcast series BJUI – BJU International · BJUI/BURST podcast: NICE guidance on UTIs in patients aged 16 and over Miss Srushti Bhat is a Urology-themed CT2 in the East Midlands and a BURST member. Twitter: @dr_srushti In this podcast she discusses the updated NICE guidance on UTIs in patients aged 16 […]
Part of the BJUI/BURST podcast series Dr Eunice Ter Zuling is a Urology registrar based in Buckinghamshire Healthcare NHS Trust. Twitter: @EuniceZuling In this podcast she discusses the BJUI paper: Radiological features characterising indeterminate testes masses: a systematic review and meta-analysis Eunice is part of BURST urology. British Urology Researchers in Surgical Training (BURST) is […]